Explore the complete list of API intermediates and key starting materials (KSMs) manufactured by Shenzhen Haorui Pharmatech Co Ltd. Trusted global supplier with verified product lists, certifications, and compliance details through apicule’s global sourcing platform.
Country: China
API Intermediate Supplier Description: Shenzhen Haorui Pharmatech Co., Ltd. (also known as Shenzhen Haorui Industrial Development Co., Ltd.) is an integrated pharmaceutical enterprise established in 1997 and headquartered in the Nanshan District of Shenzhen, China. According to the official Haorui company profile, the company functions as a combined Contract Research Organization (CRO) and Contract Manufacturing Organization (CMO). They specialize in the development, scaling, and global supply of Active Pharmaceutical Ingredients (APIs), advanced intermediates, cosmetic ingredients, veterinary products, and food additives. Operating four regional manufacturing sites across China—including their core US-FDA and EU GMP-approved plant (Hubei Haosun Pharmaceutical Co., Ltd.)—the company maintains a high technical specialization in oncology and high-potency APIs like Dasatinib, Irinotecan HCl, Docetaxel, and Temozolomide. Alongside direct manufacturing, Haorui actively assists international pharmaceutical clients with regulatory compliance, written confirmations, and the domestic registration of Finished Dosage Forms (FDF). - Show More
